Notice of Intent to Sole Source: Life Technologies Corp. Custom Taqman Array Cards Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source: Life Technologies Corp. Custom Taqman Array Cards

Deadline : 25 Aug 2023

Other Information

Notice Type : Tender

TOT Ref.No.: 87603153

Document Ref. No. : 77683LifeTechnologiesCorp

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Life Technologies Corporation for custom TaqMan Array Cards (product ID 4485460- special gene-x, con4) quantity 600 EA.

The TaqMan Array Cards (TAC) are the only commercial product that can be used for creating a custom panel of pathogen-specific assays in a microfluidic array that can be tested on existing real-time PCR systems in place in international partner laboratories supported by the Division of Bacterial Diseases and other programs within NCIRD. Ongoing customization of assays on TAC is required for specific surveillance activities, including design of new assays for new pathogens of interest (such as SARS-CoV-2) and continual improvement of real-time PCR assays for accuracy and sensitivity. Custom TAC is the only product that can be customized for inclusion of new and improved assays to address evolution of pathogens and available genome sequence data. These custom reagents are used for multi-pathogen testing of clinical specimens in various surveillance programs. This technology has been used by CDC for over 15 years, and evaluations of lab-created and clinical specimens have demonstrated that TAC has similar sensitivity and specificity to individual PCR reactions, but allows for higher throughput, reduced potential for contamination, lower cost, specimen conservation, and substantial improvement in ease of use for operator.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within four (4) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation...
Active Contract Opportunity
Notice ID : 77683LifeTechnologiesCorp
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : CENTERS FOR DISEASE CONTROL AND PREVENTION
Office : CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 21, 2023 03:56 pm EDT
Original Date Offers Due: Aug 25, 2023 03:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 09, 2023
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice

SSJ-for-NOI.pdf